Astria Therapeutics, Inc.
Astria Therapeutics, Inc.（ATXS）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
atxs · 股价预测 · 8 位分析师（近3月）· FMP · 更新于 2026年2月3日
分析师评级与共识
基于过去 3 个月内 8 位华尔街分析师
Hold
8 位分析师
共识
评级分布
12 个月目标价
High
$26.00
Consensus
$19.40
+54.2% upside
Low
$13.00
Median: $20 · Last Close: $12.58
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$19.40
54.2% upside
High Target
$26
106.7%
Low Target
$13
3.3%
Current Price
$12.58
as of today
Based on analyst price targets, the ATXS stock price prediction for the next 12 months ranges from $13 to $26. The consensus ATXS price forecast of $19.40 implies 54.2% upside from the current price of $12.58.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $12.40 | ↓ 1.43% |
1-day model range: $12.38–$12.42. Peak: $12.42 (-1.43%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $10 | -23.9% |
| 2028 | $8 | -33.9% |
| 2029 | $8 | -38.7% |
| 2030 | $7 | -41.1% |
| 2031 | — | -42.4% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
NEUTRAL
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · ATXS · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-11-12 | Cantor Fitzgerald | Downgrade ↓ | Overweight→Neutral |
| 2025-10-16 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-10-15 | JMP Securities | Downgrade ↓ | Market Outperform→Market Perform |
| 2025-10-15 | Wedbush | Downgrade ↓ | Outperform→Neutral |
| 2025-10-14 | Jefferies | Downgrade ↓ | Buy→Hold |
| 2025-09-17 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2025-09-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-08-13 | JMP Securities | Maintains | Market Outperform→Market Outperform |
| 2025-06-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Astria Therapeutics, Inc. (ATXS) stock. Of the recent 49 rating actions, 0 were upgrades and 5 were downgrades. 8 analysts currently cover ATXS.
分析师推荐趋势
ATXS analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$16M
↑ 69.3% YoY
Revenue Next Year
$4M
↓ 75.0% YoY
EPS This Year
$-1.99
EPS Next Year
$-2.14
↑ 7.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast ATXS EPS of $-1.99 for the current fiscal year, based on estimates from 3 analysts. The ATXS revenue forecast is $16M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
ATXS 股价预测由两类独立数据源支撑：来自 8 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。ATXS 的共识目标价为 $19.40（+54.2% 上行空间），分析师共识为 Hold。
ATXS 的短期预测（明日）为 $12.40（-1.43%）。 ATXS 对 2027 年的股价预测均值为 $10。 ATXS 对 2030 年的预测区间为 $7–$8。
Astria Therapeutics, Inc. 在 NASDAQ 上市，代码 ATXS。ATXS 在 2027 年的整体展望偏中性/分化，在覆盖分析师中约 38% 对应 Hold 共识。
常见问题
ATXS 预测 · 8 个问题根据 8 位华尔街分析师，ATXS 的 12 个月平均目标价为 $19.40，最高 $26.00、最低 $13.00。若有图表，中位目标价可在上方查看。相对当前价 $12.58，隐含约 +54.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.